This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Viracta Therapeutics Inc.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Marshelle Smith Warren: Innovator in Cancer Treatment
Introduction
Marshelle Smith Warren is a notable inventor based in Cardiff, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic methods.
Latest Patents
Marshelle holds a patent for "Methods of treating virally associated cancers with histone deacetylase inhibitors." This patent describes certain dosing schedules and amounts that effectively prevent and manage side effects associated with histone deacetylase inhibitor (HDACi) treatment. Additionally, these schedules and dosing regimens may include treatment with an antiviral agent.
Career Highlights
Marshelle is currently associated with Viracta Therapeutics Inc., where he continues to advance his research in cancer therapies. His work focuses on improving treatment outcomes for patients suffering from virally associated cancers.
Collaborations
Marshelle collaborates with esteemed colleagues, including Robert McRae and Gail L. Brown, who contribute to his research efforts and the development of innovative treatment methods.
Conclusion
Marshelle Smith Warren's contributions to cancer treatment through his patented methods highlight his dedication to improving patient care and advancing medical science. His work continues to inspire innovation in the field of oncology.